Alcanza Doses First Patient in Novel Alzheimer's Trial - Alcanza Clinical Research

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 08/15/2025

Alcanza Doses First Patient in Novel Alzheimer’s Trial

The Alcanza team at NeuroStudies has successfully dosed the first patient in a first-in-human clinical trial for a novel antibody targeting Alzheimer’s Disease.

Alcanza is honored to be selected as one of only three U.S. sites entrusted with this important milestone. The first patient enrolled was the first person globally, out of more than 8 billion people, to receive this investigational therapy. It’s a powerful reminder of the significance of early-phase research in advancing new treatment possibilities.

Sincere thanks go to Dr. Marshall L Nash, MD, CPI, FAHA, FAPCR, FAAN, and the dedicated NeuroStudies site staff, especially our Site Director Adrienne Hilliard, Site Manager Stefan Ilic, and Lead CRC Stephen Bocarro, as well as our Pharmacy Manager, Veronica S. Walker, PharmD, SHRM-PMQ and Pharmacy Lead Carolyn Simms, CPhT, CSPT, for their commitment to excellence.

We are grateful for the confidence placed in us by the FDA, IRB, CRO, sponsor, and our colleagues at Alcanza as we continue our shared mission to advance new treatment options for patients and families impacted by Alzheimer’s Disease.

Back

Articles

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height